Last reviewed · How we verify
Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome (MPH_IBS)
The use of natural bioactive products for prevention and treatment of a wide spectrum of conditions, including gastrointestinal disorders and conditions is well known. Based on current evidences, the scientific validity of such products is limited. However, there is sufficient preliminary data to indicate that bioactive compounds may be novel for potentially clinical use, thus further clinical trials investigating effect are needed. This trial is meant to evaluate the effect of an marine protein hydrolysate (MPH) supplement on composition of microbiota, inflammatory markers and symptom severity in people diagnosed with irritable bowel syndrome.
Details
| Lead sponsor | Helse Møre og Romsdal HF |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 40 |
| Start date | Mon Jan 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Apr 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Irritable Bowel Syndrome
Interventions
- MPH_active
- MPH_placebo
Countries
Norway